SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors aggressively position themselves ahead of the upcoming Phase 2 top-line data readout for ABCL635, a key milestone that the community views as a major clinical validation for the company's AI-driven drug discovery platform. Market participants are intensely debating the stock's potential for a short squeeze and long-term re-rating, fueled by recent institutional accumulation and high-profile pharmaceutical partnerships that have sparked significant speculative volume.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors closely monitor the critical 80th event milestone in the REGAL Phase 3 trial, with mounting speculation regarding institutional accumulation and a potential lucrative buyout. The community remains divided between intense bullish sentiment focused on the stock's role as a groundbreaking oncology platform and bearish concerns over trial timelines and clinical execution.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is trending as investors weigh the company's decision to slow development on its Reko Diq project in Pakistan due to regional security risks, sparking debate over capital expenditure and long-term project viability. The community is actively discussing the stock's valuation and strategic outlook as they balance potential for future production against ongoing geopolitical headwinds.

Themes ETF Trust - Leverage Shares 2X Long SPCX Daily ETF

Leverage Shares 2x Long SPCX Daily ETF

SPCH is experiencing intense trading activity as retail investors utilize the 2x leveraged ETF to capitalize on the high volatility surrounding SpaceX's stock movements. Community discussion is heavily focused on timing entry and exit points amid speculative price swings, with many traders debating the risks of holding leveraged assets versus using them for short-term momentum scalps.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is experiencing heightened investor interest and increased volume as the community monitors its performance ahead of an earnings report that analysts expect to be a major catalyst. Market participants are actively debating the potential for a breakout, driven by the company's backlog expansion and competitive positioning in the space launch sector, even as some traders remain cautious regarding volatility surrounding broader sector trends.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is currently trending as investors debate the impact of broader space-sector volatility following recent IPO activity and recurring institutional interest from major tech firms. While some community members express frustration over recent price corrections and equity offerings, others remain focused on the company's long-term geospatial data backlog and its integration into evolving AI and defense infrastructure.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is currently experiencing heightened volatility and intense community scrutiny as investors react to a new patent infringement lawsuit while monitoring technical key levels and upcoming earnings. The community remains polarized, balancing high-conviction excitement over the company's role in AI data center power infrastructure against significant skepticism regarding its ongoing legal challenges and the need for tangible contract announcements.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

Coherent Corp is trending as a pivotal player in AI infrastructure, driven by intense demand for optical networking components and laser technology as hyperscalers scale compute clusters. The community is actively discussing the stock's role in addressing the physical bottlenecks of data transmission, buoyed by significant strategic investments and a record-breaking backlog that extends through 2028.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is trending as investors monitor supply chain shifts, including potential U.S. restrictions on Chinese optical components, while preparing for critical earnings catalysts that highlight the company's role as a bottleneck in the booming AI infrastructure buildout. The community is actively debating the durability of the AI optics trade, balancing concerns over valuation pullbacks with strong institutional confidence in the sector's long-term capacity requirements.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is experiencing heightened retail debate as investors weigh the long-term potential of the company's strategic shift and eBay investment against persistent dilution concerns. Sentiment remains deeply polarized, with the community actively tracking institutional accumulation, short interest levels, and potential catalysts tied to ongoing corporate negotiations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CVRx (CVRX) Reports Q2 Loss, Beats Revenue Estimates

CVRx (CVRX) delivered earnings and revenue surprises of -1.92% and +0.40%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

NeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today provided an update on the U.S. Food and Drug Administration review of the Companys Premarket Approval Panel Track Supplement seeking to expand the labeled indication for...

Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now

NPCE's RNS adoption, referral growth and AI innovation support expansion, while IGE timing and investments may pressure near-term profits.

NeuroPace, Inc. (NPCE) Reveals FDA Approval of ECoG Assistant(TM)

NeuroPace, Inc. (NPCE) Reveals FDA Approval of ECoG Assistant...

Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 27.88%: Here's is How to Trade

The mean of analysts' price targets for NeuroPace (NPCE) points to a 27.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

NeuroPace (NPCE) Down 0.6% Since Last Earnings Report: Can It Rebound?

NeuroPace (NPCE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Add NeuroPace Stock to Your Portfolio Now

NPCE rides strong RNS adoption and AI tools nearing FDA review, with a mid-2026 IGE decision offering upside despite near-term losses.

NPCE Receives FDA Approval for AI-Powered ECoG Assistant for Epilepsy

NeuroPace wins FDA OK for ECoG Assistant, its first AI feature for epilepsy care, leveraging RNS EEG data to speed ECoG review and insights.

NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company will participate in the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting, taking place May 29 June 2, 2026 in...

NeuroPace Announces FDA Approval of ECoG Assistant, Advancing AI-Driven Epilepsy Care

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced FDA approval of ECoG Assistant, its first AI-driven clinician-enabled feature. This milestone represents an important step in NeuroPaces broader AI platform...

$NPCE Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.20 up 4.76% YoY
• Reported revenue of $22.07M down -2.02% YoY
• NeuroPace raised full year 2026 revenue guidance to $99M to $101M and increased Adjusted EBITDA guidance to a loss between -$8.5M and -$9.5M, reflecting underlying RNS growth.

NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.

NeuroPace Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

NPCENeuroPace Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest NPCE News